Ads
related to: oncology
Search results
CG Oncology reports promising bladder cancer trial results By Investing.com
Investing.com· 3 hours agoCG Oncology, Inc. (NASDAQ: CGON), a biopharmaceutical company engaged in the development of oncology...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 12 hours agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
It's Unlikely That Ikena Oncology, Inc.'s (NASDAQ:IKNA) CEO Will See A Huge Pay Rise This Year
Simply Wall St. via Yahoo Finance· 5 days agoKey Insights Ikena Oncology's Annual General Meeting to take place on 7th of June CEO Mark...
How to reduce health care’s climate impact? Increase telehealth
NPR· 11 hours agoBy moving online all oncology visits that need not be done in person and by allowing patients to have blood drawn and other tests and procedures performed at clinics closer ...
ArriVent partners Alphamab to develop ADCs for cancer
Pharmaceutical Technology via Yahoo Finance· 12 hours agoArriVent BioPharma has entered a partnership with Alphamab Oncology subsidiary Jiangsu Alphamab...
Cancer patients say they were turned away from New Mexico hospital
The Independent via Yahoo News· 1 day agoSeveral oncology patients say they were turned away from a hospital in rural New Mexico, where...
Race Oncology gains A$5 million for clinical programs through bonus options offer By Proactive...
Investing.com· 20 hours agoRace Oncology Ltd (ASX:RAC, OTC:RAONF) has secured A$5 million in additional capital to bolster the...
Analyst Report: Bristol-Myers Squibb Co.
Argus Research via Yahoo Finance· 3 hours agoBristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and cardiovascular conditions. The company completed its ...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 16 hours agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
Zacks via Yahoo Finance· 7 hours agoRepare (RPTX) rises 14% as the FDA grants Fast Track designation to its investigational...
